Literature DB >> 34150360

Capturing Clinical Symptoms with Ecological Momentary Assessment: Convergence of Momentary Reports of Psychotic and Mood Symptoms with Diagnoses and Standard Clinical Assessments.

Philip D Harvey1,2,3,4,5,6, Michelle L Miller1,2,3,4,5,6, Raeanne C Moore1,2,3,4,5,6, Colin A Depp1,2,3,4,5,6, Emma M Parrish1,2,3,4,5,6, Amy E Pinkham1,2,3,4,5,6.   

Abstract

Objective: The development and deployment of technology-based assessments of clinical symptoms are increasing. This study used ecological momentary assessment (EMA) to examine clinical symptoms and relates these sampling results to structured clinical ratings.
Methods: Three times a day for 30 days, participants with bipolar disorder (n=71; BPI) or schizophrenia (n=102; SCZ) completed surveys assessing five psychosis-related and five mood symptoms, in addition to reporting their location and who they were with at the time of survey completion. Participants also completed Positive and Negative Syndrome Scale (PANSS) interviews with trained raters. Mixed-model repeated-measures (MMRM) analyses examined diagnostic effects and the convergence between clinical ratings and EMA sampling.
Results: In total, 12,406 EMA samples were collected, with 80-percent adherence to prompts. EMA-reported psychotic symptoms manifested substantial convergence with equivalent endpoint PANSS items. Patients with SCZ had more severe PANSS and EMA psychotic symptoms. There were no changes in symptom severity scores as a function of the number of previous assessments. Conclusions: EMA surveyed clinical symptoms converged substantially with commonly used clinical rating scales in a large sample, with high adherence. This suggested that remote assessment of clinical symptoms is valid and practical and was not associated with alterations in symptoms as a function of reassessment, with additional benefits of "in the moment" sampling, such as eliminating recall bias and the need for informant reports.
Copyright © 2021. Matrix Medical Communications. All rights reserved.

Entities:  

Keywords:  Schizophrenia; bipolar disorder; depression; ecological momentary assessment; psychosis

Year:  2021        PMID: 34150360      PMCID: PMC8195558     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  37 in total

1.  Computerized experience sampling method (ESMc): assessing feasibility and validity among individuals with schizophrenia.

Authors:  David Kimhy; Philippe Delespaul; Cheryl Corcoran; Hongshik Ahn; Scott Yale; Dolores Malaspina
Journal:  J Psychiatr Res       Date:  2005-11-21       Impact factor: 4.791

2.  Patient compliance with paper and electronic diaries.

Authors:  Arthur A Stone; Saul Shiffman; Joseph E Schwartz; Joan E Broderick; Michael R Hufford
Journal:  Control Clin Trials       Date:  2003-04

3.  Feasibility, acceptability, and preliminary efficacy of a smartphone intervention for schizophrenia.

Authors:  Dror Ben-Zeev; Christopher J Brenner; Mark Begale; Jennifer Duffecy; David C Mohr; Kim T Mueser
Journal:  Schizophr Bull       Date:  2014-03-08       Impact factor: 9.306

4.  Mobile assessment in schizophrenia: a data-driven momentary approach.

Authors:  Margreet Oorschot; Tineke Lataster; Viviane Thewissen; Marieke Wichers; Inez Myin-Germeys
Journal:  Schizophr Bull       Date:  2011-11-29       Impact factor: 9.306

5.  Analysis of affective instability in ecological momentary assessment: Indices using successive difference and group comparison via multilevel modeling.

Authors:  Seungmin Jahng; Phillip K Wood; Timothy J Trull
Journal:  Psychol Methods       Date:  2008-12

6.  Negative Symptom Dimensions of the Positive and Negative Syndrome Scale Across Geographical Regions: Implications for Social, Linguistic, and Cultural Consistency.

Authors:  Anzalee Khan; Lora Liharska; Philip D Harvey; Alexandra Atkins; Daniel Ulshen; Richard S E Keefe
Journal:  Innov Clin Neurosci       Date:  2017-12-01

7.  Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme.

Authors:  Dragana Bugarski-Kirola; Nakao Iwata; Snjezana Sameljak; Carol Reid; Thomas Blaettler; Laurie Millar; Tiago Reis Marques; George Garibaldi; Shitij Kapur
Journal:  Lancet Psychiatry       Date:  2016-11-02       Impact factor: 27.083

8.  Mathematically Modeling Anhedonia in Schizophrenia: A Stochastic Dynamical Systems Approach.

Authors:  Gregory P Strauss; Farnaz Zamani Esfahlani; Eric Granholm; Jason Holden; Katherine Frost Visser; Lisa A Bartolomeo; Hiroki Sayama
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 7.348

9.  Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial.

Authors:  Christoph U Correll; Robert E Davis; Michal Weingart; Jelena Saillard; Cedric O'Gorman; John M Kane; Jeffrey A Lieberman; Carol A Tamminga; Sharon Mates; Kimberly E Vanover
Journal:  JAMA Psychiatry       Date:  2020-04-01       Impact factor: 21.596

10.  Feasibility and validity of computerized ecological momentary assessment in schizophrenia.

Authors:  Eric Granholm; Catherine Loh; Joel Swendsen
Journal:  Schizophr Bull       Date:  2007-10-10       Impact factor: 9.306

View more
  5 in total

1.  A cross-diagnostic study of Adherence to Ecological Momentary Assessment: Comparisons across study length and daily survey frequency find that early adherence is a potent predictor of study-long adherence.

Authors:  Sara E Jones; Raeanne C Moore; Amy E Pinkham; Colin A Depp; Eric Granholm; Philip D Harvey
Journal:  Pers Med Psychiatry       Date:  2021-07-16

2.  Momentary severity of psychotic symptoms predicts overestimation of competence in domains of everyday activities and work in schizophrenia: An ecological momentary assessment study.

Authors:  Ellaheh Gohari; Raeanne C Moore; Colin A Depp; Robert A Ackerman; Amy E Pinkham; Philip D Harvey
Journal:  Psychiatry Res       Date:  2022-02-25       Impact factor: 11.225

Review 3.  Measuring functional outcomes in schizophrenia in an increasingly digital world.

Authors:  Anja Searle; Luke Allen; Millie Lowther; Jack Cotter; Jennifer H Barnett
Journal:  Schizophr Res Cogn       Date:  2022-04-07

4.  Daily Ecological Momentary Assessments of happy and sad moods in people with schizophrenia and bipolar disorders: What do participants who are never sad think about their activities and abilities?

Authors:  Sara E Jones; Raeanne C Moore; Colin A Depp; Robert A Ackerman; Amy E Pinkham; Philip D Harvey
Journal:  Schizophr Res Cogn       Date:  2021-06-16

5.  A Longitudinal Examination of Real-World Sedentary Behavior in Adults with Schizophrenia-Spectrum Disorders in a Clinical Trial of Combined Oxytocin and Cognitive Behavioral Social Skills Training.

Authors:  Julia Browne; Philip D Harvey; Robert W Buchanan; Deanna L Kelly; Gregory P Strauss; James M Gold; Jason L Holden; Eric Granholm
Journal:  Behav Sci (Basel)       Date:  2022-02-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.